CVS Caremark Zepbound Coverage Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
CVS Caremark · Coverage of Zepbound and Wegovy obesity medications under commercial pharmacy-benefit plans · Other
Last updated
About this case
Patients filed a class-action lawsuit against CVS Caremark over its decision to exclude Eli Lilly’s Zepbound from coverage while continuing to cover rival obesity drug Wegovy. The plaintiffs allege that the drugs are not medically interchangeable and that some patients experienced weight regain after switching; the current procedural stage is not specified.
Case overview
- Defendant company
- CVS Caremark
- Product or service
- Coverage of Zepbound and Wegovy obesity medications under commercial pharmacy-benefit plans
- Court case number
- 1:2025cv07307
- Case status
- Other
- Lawsuit type
- Consumer
- Reported harm
- Other
Participation information
Availability is based on each listed participation option and its deadline.
No active participation options are currently listed.
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- CVS Caremark Zepbound Coverage Class Action
The Boston Globe ·